Methotrexate in Giant-cell Arteritis
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot study.
Koster M, Crowson C, Giblon R, Jaquith J, Duarte-Garcia A, Matteson E Ann Rheum Dis. 2022; 81(6):861-867.
PMID: 35190385 PMC: 9592156. DOI: 10.1136/annrheumdis-2021-221961.